• 보건행정학회지
• /
• 제31권2호
• /
• pp.145-147
• /
• 2021

The ethical environment in academic research is rapidly changing at a global level. Further, social expectations and public interest toward research ethics are also escalating in Korea. Understanding and applying ethical issues in academic research has become increasingly important. To conform to such changes in the ethical environment, the official journal of the Korean Academy of Health Policy and Management has been consistently establishing and modifying rules and principles regarding research ethics. For instance, we amended the submission guidelines to further address the policies for gendered innovations. For this editorial of the current issue, we would like to organize and share several ethical concerns, which recently gained considerable attention. We hope this review provides scholars with practical guidelines to comprehend and incorporate critical ethical issues into academic research.

• 디지털융복합연구
• /
• 제10권10호
• /
• pp.55-60
• /
• 2012

본 논문은 학술논문 투고관리시스템의 소개 및 발전방향에 대하여 연구하였다. 학술논문 투고관리 시스템은 논문저자에게 되도록 빠르고 편리한 학술지 게제를 제공하고, 논문심사자가 공정하고 편리하게 심사할 수 있도록 시스템을 제공한다. 현재 우리나라는 KISTI(Korea Institute of Science and Technology Information, 한국과학기술정보연구원)가 무상으로 제공하고 있는 KISTI-ACOMS가 보급되고 있으며 또한 각 학회들은 자신들에 맞는 투고관리시스템을 개발하여 사용하고 있다. 앞으로도 지속적인 개선을 통해 발전해 나아갈 것으로 사료된다. 본 논문에서는 학술논문투고관리에 전형적인 심사, 수정, 게재 등에 대하여 설명하고 올바른 방향으로 나아갈 수 있도록 제시하고자 한다.

• 여성건강간호학회지
• /
• 제13권3호
• /
• pp.211-218
• /
• 2007

Purpose: This study aimed to evaluate the accuracy and adequacy of research papers reporting statistical testings for mean differences. Methods: Original research articles utilized t-test, Chi-square test, and ANOVA were reviewed from Korean Journal of Women Health Nursing published from the year 2004 to 2006. Seventy-six papers were evaluated in accordance with formatted criteria in respect to an inclusiveness of research title, accuracy of statistical methods and presentation styles, and errors in reporting statistical outcomes. Results: Research titles were quite comprehensive, however overall accuracy of statistical values and basic formats reached only 60 to 80% by items. Details of the presentation in the reporting of outcomes were not complied with the guidelines, which need careful concerns of the writers. Errors of English in table presentation were found in more than 30% of the papers. Conclusion: The outcome would be reflected in the submission guidelines for future writers. To reach the level comparable with internationally recognized nursing journals, concrete knowledge to apply statistical methods should be ensured in the processes of submission, reviews, and editing.

• Journal of Medicine and Life Science
• /
• 제15권1호
• /
• pp.31-35
• /
• 2018

'The Journal of Medicine and Life Science' renewed editorial board and guidelines for authors, and opened online submission system (http://www.jops.co.kr/ojms/JMLS). Herein I, editor-in-chief of 'The Journal of Medicine and Life Science', did self-assessment on the history and current status of the journal and suggested perspectives on the journal.

• 여성건강간호학회지
• /
• 제14권3호
• /
• pp.213-221
• /
• 2008

Purpose: This study aimed to examine the accuracy and adequacy of research papers reporting statistical testings for correlation and regression. Method: Original research articles utilized correlation and regression analysis were reviewed from the Korean Journal of Women Health Nursing published from the year 2004 to 2006. Thirty-six papers were evaluated in accordance with formatted criteria in respect to an inclusiveness of research title, accuracy of statistical methods and presentation styles, and errors in reporting statistical outcomes. Result: Thirty articles (83.3%) utilized Pearson's correlational analysis, and ten articles did regression analysis. Lack of accurate understanding and interpretation of the statistical method was a main fault. Basic assumptions and diagnostic testings for each statistical method were not performed or described in most of the studies. Some points like consistency of research questions with statistical methods and criteria for sample size were still left out in part. Details of the presentation in the reporting of outcomes were not complied with the guidelines, which need careful concerns of the writers. Errors in English of result tables were found in more than one third of the tables. Conclusion: The outcome would be reflected in the submission guidelines for future writers. To reach the level comparable with internationally recognized nursing journals, concrete knowledge to apply statistical methods should be ensured in the processes of submission, reviews, and editing.

• 통합자연과학논문집
• /
• 제4권4호
• /
• pp.315-322
• /
• 2011

This study was performed to investigate the current regulatory guidances of safety and efficacy evaluation for the approval of stereoisomeric drugs in Korea and US. According to the regulatory guidelines in major countries (EU, Canada, US), the important categories for the development of stereoisomeric drugs are classified as 1) development of a single enantiomer as a new active substances 2) development of a racemate as a new active substance 3) development of a new single enantiomer from an approved racemate. For this study, domestic regulatory documents for current guidelines of stereoisomeric drugs were investigated. Also four typical stereoisomeric drugs for three categories were chosen to investigate the new drug submission documents of KFDA and FDA for the safety and efficacy evaluation of stereoisomeric drugs. It is expected that these comparative results between KFDA and FDA will be useful for the safety and efficacy for the regulatory approval of stereoisomeric drugs in Korea.

• 대한한의학회지
• /
• 제41권2호
• /
• pp.80-95
• /
• 2020

Objectives: The purpose of this study is to assess the quality of the Journal of Korean medicine case reports. Methods: Case reports published in the Journal of Korean Medicine from January 2015 to March 2020 were selected by using Oriental Medicine Advanced Searching Integrated System (OASIS) and the journal search system of the Korean Medical Association (https://www.jkom.org). The quality of the case reports was assessed using the Consensus-based Clinical Case Reporting Guideline Development (CARE) guidelines. Results: 33 case reports were selected for the assessment. Based on the CARE guidelines, 61.54% of the case reports included necessary information, but the quality level was uneven. More than 60% of the reports were missing data regarding 'Discussion of the strengths and limitations in your approach to this case', 'Intervention adherence and tolerability', 'Timeline', 'Medical, family, and psychosocial history including relevant genetic information', 'Patient perspective or experience', 'Adverse and unanticipated events', 'Administration of intervention', and 'De-identified demographic information and other patient specific information'. In most reports of over 90%, data regarding 'Diagnostic challenges', 'Intervention adherence and tolerability', and 'Key word' were not included. Conclusions: Efforts are needed to improve the quality of case reports in the Journal of Korean Medicine, and it is necessary to develop appropriate guidelines for case reporting for the Journal of Korean Medicine. In addition, all articles submitted to the Journal of Korean Medicine are to be complied with submission instructions and CARE guidelines.

• 기술혁신학회지
• /
• 제16권2호
• /
• pp.424-443
• /
• 2013

교육과학기술부와 한국연구재단은 창의적 도전적 연구를 적극 장려하고자 2012년 기초연구사업 중점 추진방향으로 '한국형 그랜트' 지원 방식을 도입하였으며, 이에 따라 연구자가 추후 과제 신청시 기존 연구수행 성과를 집중적으로 평가 받게 되었다. 이에, 선정평가에서 과제관리 및 종료평가에 이르는 전주기적 성과관리 시스템의 필요성이 크게 대두되었다. 본 연구에서는 전주기적 성과관리 시스템의 첫 단계로 분야별 연구실적의 정량적 가이드라인를 제시하여 연구역량평가의 보조적 수단으로 사용할 방안을 도출하고자 하였다. 그 결과, 상위그룹 간 비교 시에는 순위보정영향력지수(Ranked Normalized Impact Factor, rnIF), 하위그룹 간 비교 시에는 영향력지수(Impact Factor, IF) 또는 rnIF를 정량가이드라인으로 제안하였다. SCI급 논문 수는 동일 분류 내 위상비교 또는 동일 위상내 분류별 비교 등에 사용할 것을 제안하였다.

• 한국산학기술학회논문지
• /
• 제14권11호
• /
• pp.5897-5905
• /
• 2013

도로분야에 BIM을 활용하여 수량산출, 설계예산서 작성, 공정관리, 간섭검토 등을 하고자 하나 이를 위해 필요한 적절한 지침이나 가이드라인 등 관련 기준이 마련되어 있지 않아 BIM 적용에 어려움을 호소하고 있다. 이에 도로분야 BIM 성과품 납품체계 개발을 위해 국내외적으로 배포되어 있는 다양한 토목 BIM 관련 가이드라인 및 발주문서 등을 수집하여 특징을 분석하였다. 분석은 성과품 목록, 납품파일 형식, 기존 2D 기반의 성과품 활용여부, 성과품 제작도구, 성과품 납품방법 등 5가지 주제로 나누어 진행하였다. 분석결과 BIM 활용용도에 따라 성과품 목록, 제작도구 등이 달라 표준화하는데 많은 노력이 필요한 반면, 납품파일 형식이나 납품방법은 유사하여 공통적인 가이드 제시가 용이할 것으로 분석되었다. 더불어 당분간 BIM기반의 성과품이 2D성과품을 대체하기는 어려워 병행하여 납품받아야 할 것으로 판단된다. 본 논문의 연구결과는 향후 도로분야 BIM 성과품 납품체계 개발을 위한 근간자료로 활용될 수 있을 것이다.

• 한국임상약학회지
• /
• 제31권1호
• /
• pp.53-60
• /
• 2021

Objective: To gather the opinions of hands-on workers for successful introduction of the Development Safety Update Report (DSUR) according to a five-year comprehensive plan for clinical trial development [Ministry of Food and Drug Safety, 2019]. Methods: We conducted a survey on considerations that industry stakeholders may have related to the enforcement of the DSUR. A questionnaire was distributed among pharmacovigilance specialists from 13 pharmaceutical companies in South Korea on June 4, 2020. The questionnaire comprised two sections: 1) current status of the Drug Safety Data Management System and 2) considerations on the implementation and management of the DSUR. Results: All respondents have agreed the introduction of DSUR is inevitable for regulatory harmonization and safety of trial subject. However, most respondents (85%) felt concern about additional workload with DSUR implementation. They answered that format and operation system of DSUR should be harmonized with those of international standards and authorities need to minimize double burden due to related report. Conclusion: All respondents asserted that domestic DSUR should be harmonized with International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E2F guidelines. Respondents from global companies also suggested regulatory authorities allow DSUR written in English to replace Korean version considering their deadline for submission. Moreover, every respondent agreed regulatory authorities need delicate effort when implementing mandatory submission of DSUR to ensure that even small pharmaceutical companies with no experience in DSUR can comply with the system.